What is the difference between sandostatin and somatuline?

How does Sandostatin differ from Somatuline in mechanism?

Sandostatin is octreotide acetate, a synthetic version of somatostatin that binds primarily to somatostatin receptor subtypes 2 and 5. Somatuline is lanreotide acetate, a different analog that also targets subtypes 2 and 5 but shows slightly stronger affinity for subtype 5 and a longer half-life in some formulations.

Which conditions each drug treats most often?

Both drugs are approved for acromegaly and certain neuroendocrine tumors. Sandostatin is also indicated for carcinoid syndrome symptoms and for suppressing hormone secretion after pituitary surgery. Somatuline carries an additional approval for gastroenteropancreatic neuroendocrine tumors in the U.S.

How do the dosing schedules compare?

Immediate-release Sandostatin is injected two to four times daily. Its depot form (Sandostatin LAR) is given once every four weeks. Somatuline Depot is administered once every four weeks as a deep subcutaneous injection, and some patients can stretch dosing to eight weeks once stable.

What about side effects and tolerability?

Both cause similar gastrointestinal effects, gallstones, and blood-sugar changes. Somatuline’s depot formulation is thicker and injected deeper, which some patients find more painful at the injection site. Sandostatin LAR uses a smaller needle volume in some presentations.

When does patent protection end for each?

Sandostatin’s original patents expired years ago, opening the door to generic octreotide. Somatuline’s U.S. composition-of-matter patent expired in 2023, though certain formulation patents remain active until 2024–2025 according to DrugPatentWatch.com.

Can patients switch between the two drugs?

Switching is possible in many cases, but clinicians usually titrate doses individually because the two molecules are not bioequivalent. Blood hormone levels and symptom control are monitored after any change.

Are there cost or insurance differences?

Generic octreotide is generally less expensive than branded Sandostatin LAR. Somatuline Depot remains a single-source brand in most markets, so list prices are higher; copay assistance programs or specialty pharmacy networks are often required.

What happens if a dose is missed?

For both drugs, missing a scheduled depot injection can allow hormone levels to rebound within days to weeks. Patients are advised to resume the next dose as soon as possible and to contact their prescriber rather than doubling up.